---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-045029"
form_type: "8-K"
ticker: null
cik: "0001622879"
company_name: "Medicine Man Technologies, Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T12:15:06.625671+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Chief Policy Officer Daniel Pabon departs Medicine Man Technologies; receives $250K severance

## Summary
- Daniel Pabon terminated as Chief Policy and Regulatory Affairs Officer effective April 30, 2025.
- Severance: $250,000 cash (12 months base salary) plus 12 months COBRA subsidy.
- Equity vesting accelerated for options vesting May 3, 2025; exercise period extended to expiration.
- Departure part of strategic restructuring to consolidate roles and eliminate redundancies.

## SEC filing metadata
- accession: 0001104659-25-045029
- form_type: 8-K
- cik: 0001622879
- company_name: Medicine Man Technologies, Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622879/000110465925045029/0001104659-25-045029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622879/000110465925045029/tm2514177d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-045029
- JSON: https://secwatch.observer/filing/0001104659-25-045029.json
- Plain text: https://secwatch.observer/filing/0001104659-25-045029.txt

## Key facts
- Executive change
  Daniel Pabon was terminated as Chief Policy and Regulatory Affairs Officer at Medicine Man Technologies, Inc..
  - Action: terminated
  - Role: Chief Policy and Regulatory Affairs Officer
  source text: On May 2, 2025, Medicine Man Technologies, Inc. (the “Company”) and Daniel Pabon, the Company’s Chief Policy and Regulatory Affairs Officer, entered into a Separation Agreement and Release (“Separation Agreement”), pursuant to which Mr. Pabon’s employment with the Company terminated effective April 30, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1622879/000110465925045029/0001104659-25-045029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.